Status:
COMPLETED
Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Collaborating Sponsors:
Centocor, Inc.
Conditions:
Crohn's Disease
Eligibility:
All Genders
Brief Summary
The current observational program was determined to collect data on the real life dosing regimen of Remicade in patients with Crohn's disease (CD) in the hospital and non-hospital setting.
Detailed Description
This study population was chosen from a non-probability sample
Eligibility Criteria
Inclusion
- Subjects with active luminal and/or fistulizing CD.
Exclusion
- Per summary of product characteristics.
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT00724958
Start Date
December 1 2004
End Date
July 1 2010
Last Update
October 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.